MAI Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
Other funds holding MDGL
BBA
MAI Capital Management's MDGL Position: Q3 2026 in Review
MAI Capital Management opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2026: 1,289 shares worth $650K. The stake represents ﹤0.01% of the portfolio and ranks #1138 among its holdings. This is a return to the name: MAI Capital Management previously reported a position in MDGL as recently as Q1 2026.
MAI Capital Management first reported a position in MDGL in Q4 2024 and has held it in 7 quarters since. 442 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.
- MAI Capital Management held 1,289 shares of Madrigal Pharmaceuticals worth $650K as of Q3 2026.
- Madrigal Pharmaceuticals was a new MAI Capital Management position in Q3 2026.
- Madrigal Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q3 2026, its #1138 holding.
- MAI Capital Management first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
- 442 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.
Based on MAI Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.